Northwire Canada EditionFriday, July 10, 2026
Northwire
TLO 5.37 +5.7% BNKR 4.88 +1.7% GG 2.25 +3.2% MJS 0.100 +5.3% PAAS 62.54 +3.6% PE 0.230 +0.0% SGML 17.19 +4.8% LAR 10.34 −1.1% NED 0.025 +0.0% GEN 0.080 +0.0% TVI 0.060 +0.0% SKYG 0.025 −37.5% WRLG 0.660 +6.5% FFU 0.120 −7.7% LOD 0.310 +3.3% CBI 0.110 +0.0% TLO 5.37 +5.7% BNKR 4.88 +1.7% GG 2.25 +3.2% MJS 0.100 +5.3% PAAS 62.54 +3.6% PE 0.230 +0.0% SGML 17.19 +4.8% LAR 10.34 −1.1% NED 0.025 +0.0% GEN 0.080 +0.0% TVI 0.060 +0.0% SKYG 0.025 −37.5% WRLG 0.660 +6.5% FFU 0.120 −7.7% LOD 0.310 +3.3% CBI 0.110 +0.0%
Financings Admin

Bravada Closes Non-Brokered Private Placement

BVA · Price

Executive Summary

  • Bravada Gold Corporation has closed its previously announced non-brokered private placement, issuing 285,715 common shares at $0.70 per share to raise approximately $200,000.
  • All shares were purchased by Dr. Paul West-Sells, who was recently appointed as the Company's President & Chief Executive Officer.
  • The transaction is structured as a related party transaction under Multilateral Instrument 61-101, with the Company relying on specific exemptions from valuation and minority shareholder approval requirements.

Key Details

  • Structure & Quantity: Non-brokered private placement of 285,715 common shares
  • Price & Proceeds: $0.70 per share; gross proceeds of $200,000.50
  • Buyer: Dr. Paul West-Sells (newly appointed President & CEO)
  • Hold Period: Shares are subject to a hold period expiring on October 23, 2026
  • Use of Proceeds: General working capital
  • Regulatory Status: Subject to final approval of the TSX Venture Exchange
  • Compliance & Exemptions: Classified as a "related party transaction" under MI 61-101; relying on exemptions from valuation and minority shareholder approval requirements per sections 5.5(a) and 5.7(1)(a) of MI 61-101, as the fair market value of the participation does not exceed 25% of the Company's market capitalization.
Read the original news release →

More from Bravada Gold Corporation